REGULATORY

Ishiba, Trump Agree to Appoint Ministers for Tariffs Talks

April 8, 2025

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Japanese Prime Minister Shigeru Ishiba and US President Donald Trump agreed during their phone call on April 7 that they will appoint ministers in charge of holding talks on the series of tariff measures announced by Washington earlier this month.…

To read the full story

MHLW Sets Up Task Force to Brace for US Tariffs
April 10, 2025
Japan Economic Minister Akazawa to Lead Tariff Talks with US
April 9, 2025

REGULATORY

Panel Clears Zolgensma Intrathecal Form to Expand Use in Older SMA Patients
March 10, 2026
Japan Approves MSD’s HIV Combo Idvynso
March 9, 2026
MHLW Updates Elective Care LLP List; Target Products Down Sharply to 776
March 9, 2026
MHLW Orders Label Revisions for Cancer Drugs, Anticoagulant over Bleeding Risk
March 9, 2026
Japan Health Minister Lauds Approval of iPSC-Based Therapies
March 9, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

ICH Weighs Need for Biosimilar Efficacy Trials as Regulators Move Away from Routine Use

By Takashi Ebisawa

International regulators are increasingly moving away from comparative efficacy studies (CES) in biosimilar development — long considered a default requirement…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…